Image Credit: Unknown author/

Medicare’s obesity-drug program requires a body mass index of 35, or 30 with heart failure, uncontrolled blood pressure or kidney disease.

Not every Medicare beneficiary who wants help losing weight qualifies for the new $50-a-month GLP-1 drug program, even if a doctor thinks it would help. Medicare GLP-1 Bridge, which began July 1, 2026, sets eligibility by body mass index, but not a single cutoff line; it uses three separate BMI thresholds, each paired with its…

Read More
Image Credit: Raimond Spekking - CC BY-SA 4.0/Wiki Commons

Medicare’s obesity-drug deal covers the Zepbound KwikPen, not the single-dose pen and not the vials.

Medicare’s new $50-a-month program for obesity drugs does not cover every version of every eligible medicine. Starting July 1, 2026, Medicare GLP-1 Bridge lets an eligible beneficiary pay a flat $50 for certain GLP-1 drugs no matter their income, but the fine print names specific products and specific delivery devices, and it excludes some forms…

Read More
Tima Miroshnichenko/Pexels

New rules on October 1 let Medicare sales agents move a caller to an enrollment faster and cut their record-keeping to six years.

Beginning October 1, 2026, the rules that govern how a licensed Medicare sales agent handles a phone call are getting looser rather than tighter. The Centers for Medicare & Medicaid Services finalized a rule in April 2026 that erases several of the waiting periods that used to separate a beneficiary’s first phone call from the…

Read More
person sitting while using laptop computer and green stethoscope near

An insurer that drops a Medicare Advantage plan is barred from new contracts for two years and must give members 90 days’ notice.

A federal regulation spells out exactly what has to happen when a Medicare Advantage insurer decides to stop offering a plan: the company must mail every affected member a notice at least 90 days before coverage ends, and the insurer itself faces a two-year lockout from starting new Medicare Advantage business. Both requirements sit in…

Read More
Image Credit: Tony Webster from Minneapolis, Minnesota, United States - CC BY-SA 2.0/Wiki Commons

The demonstration that has held down Part D premiums ends after this year, the same year the wholesale benchmark jumped 24 percent.

The bid amount that determines what Medicare Part D plans charge is jumping by roughly a quarter for 2027, according to figures the Centers for Medicare & Medicaid Services released this summer. Part of that jump traces directly to a temporary program that has been quietly absorbing some of the cost pressure on standalone drug…

Read More
a person writing on a piece of paper with a stethoscope

Medicare Advantage plans were overpaid $23.7 billion last year, and auditors say the program has never run a fraud-risk assessment.

The federal government paid Medicare Advantage plans $23.7 billion in improper payments during fiscal year 2025, and the agency that oversees those plans has never completed a comprehensive assessment of the fraud risks inside the program, according to a federal watchdog. The Government Accountability Office singled out Medicare Advantage alongside a much smaller Department of…

Read More